| Ajay K Nellutla, MD | |
|
1700 E Desert Inn Rd Ste 301, Las Vegas, NV 89169 | |
| (702) 649-8009 | |
| (702) 649-8049 |
| Full Name | Ajay K Nellutla |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 1700 E Desert Inn Rd Ste 301, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407913718 | NPI | - | NPPES |
| 1407913718 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 10766 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Dominic Home Health Care Inc | North las vegas, NV | Home health agency |
| Emerald Home Health Care, Llc | Las vegas, NV | Home health agency |
| Optimum Health Care, Llc | Las vegas, NV | Home health agency |
| Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
| Entity Name | Dr Ajay Nellutla Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356596134 PECOS PAC ID: 8729145529 Enrollment ID: O20090323000420 |
News Archive
Think Africa Press describes how "[t]he Jadelle Access Program is aiming to make Jadelle progestogen implants - a long-acting and reversible form of contraception - available to more than 27 million women in more than 50 countries worldwide."
The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.
› Verified 7 days ago
| Entity Name | Eid Nevada Critical Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962712828 PECOS PAC ID: 9537357793 Enrollment ID: O20110103000917 |
News Archive
Think Africa Press describes how "[t]he Jadelle Access Program is aiming to make Jadelle progestogen implants - a long-acting and reversible form of contraception - available to more than 27 million women in more than 50 countries worldwide."
The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.
› Verified 7 days ago
| Entity Name | Nevada Acute Medical Services-scherr 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992244438 PECOS PAC ID: 6103101738 Enrollment ID: O20170322002944 |
News Archive
Think Africa Press describes how "[t]he Jadelle Access Program is aiming to make Jadelle progestogen implants - a long-acting and reversible form of contraception - available to more than 27 million women in more than 50 countries worldwide."
The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ajay K Nellutla, MD 1700 E Desert Inn Rd Ste 301, Las Vegas, NV 89169-3207 Ph: (702) 649-8009 | Ajay K Nellutla, MD 1700 E Desert Inn Rd Ste 301, Las Vegas, NV 89169 Ph: (702) 649-8009 |
News Archive
Think Africa Press describes how "[t]he Jadelle Access Program is aiming to make Jadelle progestogen implants - a long-acting and reversible form of contraception - available to more than 27 million women in more than 50 countries worldwide."
The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.
Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.
› Verified 7 days ago
Dr. Arshi A. Quadeer, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |